Cadila Healthcare informs about press release

24 Nov 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives approval from the USFDA for Minocycline Hydrochloride Extended - Release Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

905.15 -4.85 (-0.53%)
17-Feb-2026 13:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.85
Dr. Reddys Lab 1277.00
Cipla 1343.65
Zydus Lifesciences 905.15
Lupin 2241.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×